SH3BGR
SH3 domain-binding glutamic acid-rich protein
Also known as: 21-GARP, SH3BG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55822
- Gene
- SH3BGR
- Ensembl
- ENSG00000185437
- Chromosome
- 21
- Canonical length
- 239 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable SH3 domain binding activity. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
239 residues, UniProt reviewed canonical sequence.
>P55822|SH3BGR
1 MPLLLLGETE PLKLERDCRS PVDPWAAASP DLALACLCHC QDLSSGAFPD RGVLGGVLFP
61 TVEMVIKVFV ATSSGSIAIR KKQQEVVGFL EANKIDFKEL DIAGDEDNRR WMRENVPGEK
121 KPQNGIPLPP QIFNEEQYCG DFDSFFSAKE ENIIYSFLGL APPPDSKGSE KAEEGGETEA
181 QKEGSEDVGN LPEAQEKNEE EGETATEETE EIAMEGAEGE AEEEEETAEG EEPGEDEDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SH3BGR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 1,188 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1,188 nTPM
- tongue: 573 nTPM
- heart muscle: 159 nTPM
- blood vessel: 61 nTPM
- midbrain: 42 nTPM
- colon: 38 nTPM
Single-cell type
- ependymal cells: 38 nCPM
- astrocytes: 29 nCPM
- oligodendrocytes: 25 nCPM
- choroid plexus epithelial cells: 24 nCPM
- bergmann glia: 15 nCPM
- distal convoluted tubule cells: 15 nCPM
Immune cell
- plasmacytoid DC: 3.8 nTPM
- naive CD4 T-cell: 1.6 nTPM
- memory B-cell: 1.4 nTPM
- NK-cell: 1.3 nTPM
- naive CD8 T-cell: 1.2 nTPM
- intermediate monocyte: 0.9 nTPM
Brain region
- white matter: 44 nTPM
- basal ganglia: 29 nTPM
- pons: 28 nTPM
- medulla oblongata: 27 nTPM
- hippocampal formation: 27 nTPM
- hypothalamus: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SH3BGR as an antibody target. Whether an autoantibody or antibody against SH3BGR could matter depends on whether native SH3BGR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SH3BGR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SH3BGR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...